Vanguard Group Inc Replimune Group, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,469,688 shares of REPL stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,469,688

Previous 3,833,033 9.48%

Holding current value

$16.4 Million

Previous $37.4 Million 13.75%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$6.92 - $10.38 $2.51 Million - $3.77 Million	-363,345 Reduced 9.48%	3,469,688 $32.2 Million
Q1 2025 May 09, 2025	BUY	$9.75 - $14.31 $2.31 Million - $3.39 Million	237,185 Added 6.6%	3,833,033 $37.4 Million
Q4 2024 Feb 11, 2025	BUY	$10.54 - $14.93 $1.37 Million - $1.93 Million	129,601 Added 3.74%	3,595,848 $43.5 Million
Q3 2024 Nov 13, 2024	BUY	$8.09 - $11.23 $4.62 Million - $6.41 Million	571,133 Added 19.73%	3,466,247 $38 Million
Q2 2024 Aug 13, 2024	BUY	$5.01 - $9.46 $625,177 - $1.18 Million	124,786 Added 4.5%	2,895,114 $26.1 Million
Q1 2024 May 10, 2024	BUY	$6.87 - $9.31 $223,652 - $303,087	32,555 Added 1.19%	2,770,328 $22.6 Million
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $956,164 - $2.29 Million	141,654 Added 5.46%	2,737,773 $23.1 Million
Q3 2023 Nov 14, 2023	BUY	$15.96 - $22.18 $3.87 Million - $5.37 Million	242,220 Added 10.29%	2,596,119 $44.4 Million
Q2 2023 Aug 14, 2023	SELL	$15.65 - $24.1 $445,899 - $686,657	-28,492 Reduced 1.2%	2,353,899 $54.7 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $2.44 Million - $4.06 Million	139,399 Added 6.21%	2,382,391 $42.1 Million
Q4 2022 Feb 10, 2023	BUY	$17.09 - $27.91 $6.75 Million - $11 Million	394,825 Added 21.36%	2,242,992 $61 Million
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $1.4 Million - $1.9 Million	89,618 Added 5.1%	1,848,167 $31.9 Million
Q2 2022 Aug 12, 2022	BUY	$13.32 - $19.98 $1.77 Million - $2.65 Million	132,791 Added 8.17%	1,758,549 $30.7 Million
Q1 2022 May 13, 2022	BUY	$15.24 - $29.75 $1.25 Million - $2.43 Million	81,845 Added 5.3%	1,625,758 $27.6 Million
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $428,648 - $577,318	-16,856 Reduced 1.08%	1,543,913 $41.8 Million
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $3.91 Million - $5.34 Million	135,051 Added 9.47%	1,560,769 $46.3 Million
Q2 2021 Aug 13, 2021	BUY	$28.5 - $39.37 $40.6 Million - $56.1 Million	1,425,718 New	1,425,718 $54.8 Million

Others Institutions Holding REPL

# of Institutions

195

Shares Held

77.7M

Call Options Held

2.06M

Put Options Held

2.86M

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $233M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Replimune Group, Inc. Transaction History